Lendio, Yulie S.
HRN: 26-51-26 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/07/2026
CEFTRIAXONE 1G (VIAL)
06/07/2026
06/13/2026
IV
2g
Od
Uti
Checking Initial Appropriateness
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines